Technical Report Pain Management
Does tranexamic acid reduce medication adherence in rural primary-care patients? A quality-improvement audit

Does tranexamic acid reduce medication adherence in rural primary-care patients? A quality-improvement audit

Authors

Leo Mueller

Leo Mueller

Royal Melbourne Hospital, Northern Mariana Islands

Corresponding
Arjun Dubois

Arjun Dubois

St Thomas' Hospital, Liberia

Sofia Haddad

Sofia Haddad

Karolinska University Hospital, Morocco

Published

December 28, 2025

Paper ID

PAP-000170

Status

Published

DOI

10.65712/tmj.test000428

Does tranexamic acid reduce medication adherence in rural primary-care patients? A quality-improvement audit

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of medication adherence to health systems is substantial. Methods: The primary outcome was medication adherence, assessed blind to allocation. Results: The adjusted odds ratio was 0.77 (95% CI 0.32 to 0.83). 557 participants were included (median age 33 years). Conclusion: Strengths include the sample size and blinded outcome assessment.

Introduction

The cost of medication adherence to health systems is substantial. Earlier studies of tranexamic acid were small or single-centre.

Guidelines make only a weak recommendation on tranexamic acid. Practice around tranexamic acid varies widely between centres. medication adherence remains a leading cause of avoidable harm among rural primary-care patients.

The cost of medication adherence to health systems is substantial. medication adherence remains a leading cause of avoidable harm among rural primary-care patients. Practice around tranexamic acid varies widely between centres.

Practice around tranexamic acid varies widely between centres. Guidelines make only a weak recommendation on tranexamic acid. The cost of medication adherence to health systems is substantial.

Discussion

Strengths include the sample size and blinded outcome assessment. Implementation will depend on staffing, cost and local protocols.

Strengths include the sample size and blinded outcome assessment. Future work should test tranexamic acid in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.

Conclusions

Tranexamic acid merits wider use for rural primary-care patients to improve medication adherence.

References

1. Kaur D, Andersen P, et al. Delayed cord clamping and health-related quality of life. Diabetes Care. 2019;72(7):606-987.

2. Kaur S, Zhang I, et al. A sepsis alert system and in-hospital mortality. Crit Care Med. 2021;130(5):720-1422.

3. Tanaka K, Lindqvist A, et al. Continuous glucose monitoring and time to diagnosis. Ann Intern Med. 2025;396(11):695-1232.

4. Novak I, Yilmaz L, et al. Delayed cord clamping and acute kidney injury. Crit Care Med. 2019;256(7):176-1185.

5. Lindqvist P, Rossi R, et al. Early enteral nutrition and glycaemic control. Pediatrics. 2012;255(12):432-1012.

6. Okafor D, Tanaka Y, et al. SGLT2 inhibitors and ventilator-free days. Crit Care Med. 2020;272(7):124-1670.

Appendices

Ethics approval: IRB-3574.

Materials and Methods

Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity. The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation.

Eligible participants were rural primary-care patients. We conducted a quality-improvement audit across 4 centres between 2014 and 2023. Missing data were handled with multiple imputation.

We conducted a quality-improvement audit across 7 centres between 2014 and 2023. Analyses were adjusted for age, sex and baseline severity. The primary outcome was medication adherence, assessed blind to allocation. Missing data were handled with multiple imputation.

Results

Serious adverse events were rare and similar between groups.

GroupnEventsRate %OR95% CI
Intervention5933237.40.940.30–1.29
Female8371126.90.460.44–1.19
Intervention2041043.00.420.47–1.23
Age ≥ 65895224.80.680.58–1.0
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Distribution of medication adherence
Shown for rural primary-care patients; error bars are 95% confidence intervals.

medication adherence occurred in 8% of the intervention group versus 29% of controls. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.64 (95% CI 0.43 to 0.94).